IMPAKT 2016
75 Presentations Within 20 Sessions
ELCC 2016
131 Presentations Within 31 Sessions
ESMO Asia 2015
289 Presentations Within 63 Sessions
Immuno-Oncology 2015
40 Presentations Within 12 Sessions
ESMO Academy 2015
57 Presentations Within 18 Sessions
ESMO Preceptorship on NSCLC 2015
19 Presentations Within 8 Sessions
WorldGI 2015
461 Presentations Within 18 Sessions
IMPAKT 2015
185 Presentations Within 20 Sessions
ELCC 2015
373 Presentations Within 46 Sessions
ELCC 2015 Industry Satellite Symposia
40 Presentations Within 8 Sessions
ESMO Symposium on Signalling Pathways in Cancer 2015
30 Presentations Within 9 Sessions
ESMO Symposium on Immuno-Oncology 2014
61 Presentations Within 16 Sessions
ESMO Preceptorship on Immunotherapy of Cancer 2014
35 Presentations Within 10 Sessions
ESMO 2014
2367 Presentations Within 192 Sessions
ESMO 2014 Industry Satellite Symposia
278 Presentations Within 43 Sessions
ESMO 2014: Rare Cancers Session
6 Presentations Within 1 Session
ESMO 2014 Patient Advocacy Track
50 Presentations Within 13 Sessions
ESMO 2014 Clinical Practice Guidelines Sessions
28 Presentations Within 2 Sessions
ESMO 2014 Presidential Symposium 2
5 Presentations Within 1 Session
ESMO 2014: Open access Industry Satellite Symposium
9 Presentations Within 2 Sessions
ESMO Preceptorship on Colorectal cancer 2014
32 Presentations Within 8 Sessions
World GI 2014
389 Presentations Within 21 Sessions
IMPAKT 2014
165 Presentations Within 21 Sessions
ELCC 2014
300 Presentations Within 44 Sessions
SARCOMA and GIST 2014
62 Presentations Within 14 Sessions
Signalling Pathways 2014
24 Presentations Within 10 Sessions
ESMO Symposium on Immuno-Oncology
32 Presentations Within 10 Sessions
WorldGI 2013
54 Presentations Within 14 Sessions
EMCTO 2013
235 Presentations Within 28 Sessions
Preceptorship on Prostate Cancer 2013
31 Presentations Within 9 Sessions
IMPAKT 2013
235 Presentations Within 23 Sessions
Preceptorship on Colorectal Cancer 2013
22 Presentations Within 8 Sessions
Signalling Pathways in Cancer 2013
34 Presentations Within 10 Sessions
Preceptorship on Gastric Cancer 2013
21 Presentations Within 8 Sessions
ESMO 2012 - Breast cancer
801 Presentations Within 18 Sessions
ESMO 2012 - CNS tumors
399 Presentations Within 7 Sessions
ESMO 2012 - Developmental therapeutics
414 Presentations Within 8 Sessions
ESMO 2012 - Familial cancer and Genetic syndromes
370 Presentations Within 4 Sessions
ESMO 2012 - Gastrointestinal tumors
800 Presentations Within 20 Sessions
ESMO 2012 - Genitourinary tumors
461 Presentations Within 17 Sessions
ESMO 2012 - Gynecological cancers
417 Presentations Within 10 Sessions
ESMO 2012 - Head and neck cancer
399 Presentations Within 9 Sessions
ESMO 2012 - Hematological malignancies
387 Presentations Within 9 Sessions
ESMO 2012 - Industry Satellite
238 Presentations Within 34 Sessions
ESMO 2012 - Lung cancer and other thoracic maligancies
821 Presentations Within 21 Sessions
ESMO 2012 - Melanoma and other skin tumors
389 Presentations Within 7 Sessions
ESMO 2012 - Miscellaneous
50 Presentations Within 7 Sessions
ESMO 2012 - Neuroendocrine tumors and CUP
393 Presentations Within 7 Sessions
ESMO 2012 - Oncology and public health
516 Presentations Within 33 Sessions
ESMO 2012 - Palliative and supportive care
420 Presentations Within 12 Sessions
ESMO 2012 - Patient Seminar
50 Presentations Within 14 Sessions
ESMO 2012 - Sarcoma
416 Presentations Within 9 Sessions
IMPAKT 2012
215 Presentations Within 27 Sessions
Preceptorship on NETs 2012
29 Presentations Within 9 Sessions
ELCC 2012
369 Presentations Within 49 Sessions
Sarcoma and GIST 2012
65 Presentations Within 12 Sessions
Metastases 2011 – Virtual meeting
14 Presentations Within 8 Sessions
IMPAKT 2011 – breast cancer
194 Presentations Within 23 Sessions
EMCTO 2011 – lung cancer
127 Presentations Within 19 Sessions
ESMO Symposium on Cancer Biology
25 Presentations Within 7 Sessions
ESMO 2010: Industry Symposia (restricted access)
11 Presentations Within 1 Session
ESMO 2010: Industry Symposia (By Agreement Only)
27 Presentations Within 4 Sessions
ESMO 2010: Basic science and translational research
290 Presentations Within 12 Sessions
ESMO 2010: Biomarkers
279 Presentations Within 4 Sessions
ESMO 2010: Breast cancer, advanced
278 Presentations Within 4 Sessions
ESMO 2010: Breast cancer, early
266 Presentations Within 3 Sessions
ESMO 2010: Chest tumors
321 Presentations Within 15 Sessions
ESMO 2010: Colorectal cancer
279 Presentations Within 6 Sessions
ESMO 2010: Developmental therapeutics
270 Presentations Within 4 Sessions
ESMO 2010: Gastrointestinal tumors
285 Presentations Within 10 Sessions
ESMO 2010: Genitourinary tumors
303 Presentations Within 11 Sessions
ESMO 2010: Geriatric oncology
261 Presentations Within 2 Sessions
ESMO 2010: Gynecological cancer
302 Presentations Within 10 Sessions
ESMO 2010: Head and neck cancer
286 Presentations Within 12 Sessions
ESMO 2010: Health services and public health
306 Presentations Within 13 Sessions
ESMO 2010: Hematological malignancies
288 Presentations Within 10 Sessions
ESMO 2010: Melanoma
255 Presentations Within 4 Sessions
ESMO 2010: Miscellaneous
326 Presentations Within 60 Sessions
ESMO 2010: Neuro-oncology
257 Presentations Within 2 Sessions
ESMO 2010: Neuroendocrine tumors and CUP
258 Presentations Within 3 Sessions
ESMO 2010: Palliative care
264 Presentations Within 4 Sessions
ESMO 2010: Prevention and screening
248 Presentations Within 1 Session
ESMO 2010: Psycho-oncology
253 Presentations Within 2 Sessions
ESMO 2010: Sarcoma
272 Presentations Within 8 Sessions
ESMO 2010: Supportive care
287 Presentations Within 7 Sessions
ESMO 2010: Upper gastrointestinal tumors
261 Presentations Within 3 Sessions